The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in combination with lenvatinib in patients with advanced hepatocellular carcinoma.
 
Masafumi Ikeda
Honoraria - Abbott Laboratories; Abbvie; AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Eisai; Fujifilm; Incyte; Lilly Japan; MSD; Nihonkayaku; Novartis; Ono Pharmaceutical; SERVIER; Taiho Pharmaceutical; Taisho Pharmaceutical Holdings; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Boston Scientific; Chugai Pharma; Eisai; Lilly Japan; MSD; Novartis; SERVIER; Takeda
Research Funding - AstraZeneca (Inst); Bayer Yakuhin (Inst); Bristol-Myers Squibb (Inst); Chiome Bioscience (Inst); Chugai Pharma (Inst); Delta-Fly Pharma (Inst); Eisai (Inst); InVitae (Inst); J-Pharma (Inst); Lilly Japan (Inst); Merck (Inst); Merus NV (Inst); MSD (Inst); Nihon Servier (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Syneos Health (Inst)
 
Naoya Kato
Speakers' Bureau - Abbott; Abbvie; Aska Pharmaceutical Co., Ltd.; Astellas Pharma; AstraZeneca Japan; Bayer Yakuhin; Bristol-Myers Squibb Company; Chugai Pharma; Covidien; Daiichi Sankyo Co.,Ltd.; EA Pharma; Eisai; Fujifilm; Gilead Sciences; Kowa; Lilly Japan; Mitsubishi Tanabe Pharma; Miyarisan pharmaceutical; Mochida Pharmaceutical Co. Ltd.; MSD K.K; Mylan; Nichi-iko; Nippon Kayaku; Nobelpharma; Olympus; Ono Pharmaceutical; Otsuka; Shionogi; Sumitomo Dainippon Pharma Co., Ltd.; Takeda; Tsumura & Co.; Zeria Pharmaceutical
Research Funding - Abbvie (Inst); Asahi Kasei (Inst); Asahi Kasei (Inst); Aska Pharmaceutical Co.,Ltd. (Inst); Astellas Pharma (Inst); Boston Scientific (Inst); Chugai Pharma (Inst); Covidien (Inst); CYTLIMIC (Inst); Daiichi Sankyo co.,Ltd. (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); JIMRO (Inst); Kowa (Inst); Medicos Hirata (Inst); Mitsubishi Tanabe Pharma (Inst); Mochida Pharmaceutical Co. Ltd. (Inst); MSD K.K. (Inst); Nippon Kayaku (Inst); Otsuka (Inst); Shionogi (Inst); Sumitomo Dainippon Pharma Co.,Ltd. (Inst); Takeda (Inst); Tsumura & Co. (Inst)
 
Shunsuke Kondo
Honoraria - Chugai Pharma; Eisai; Incyte
Consulting or Advisory Role - Takeda
Speakers' Bureau - Incyte
Research Funding - Abbvie; AstraZeneca; Eisai; Lilly O.
 
Yoshitaka Inaba
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai
Research Funding - AstraZeneca; Chugai Pharma; Eisai
 
Kazuomi Ueshima
Honoraria - Abbvie; AstraZeneca; Asuka Seiyaku; Bayer; Chugai Pharma; EA Pharma; Eisai; Kowa; Lilly Japan; MSD; Otsuka; Sumitomo Group; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Chugai Pharma; Eisai; Lilly Japan; Pfizer; Takeda
 
Mitsuhito Sasaki
No Relationships to Disclose
 
Hiroaki Kanzaki
Honoraria - Eisai
Speakers' Bureau - Bayer Yakuhin; Takeda
 
Hiroshi Ida
No Relationships to Disclose
 
Hiroshi Imaoka
Honoraria - Medico's Hirata
Consulting or Advisory Role - Nihon Servier
Research Funding - Ono Pharmaceutical
 
Yasunori Minami
No Relationships to Disclose
 
Shuichi Mitsunaga
Honoraria - Ono Pharmaceutical; Otsuka; Toray Industries
Speakers' Bureau - Ono Pharmaceutical
Research Funding - Ajinomoto; Astellas Pharma; Chugai Pharma; Pfizer; Toray Industries
Patents, Royalties, Other Intellectual Property - Chugai Pharma (Inst); Toray Industries (Inst)
 
Naoshi Nishida
No Relationships to Disclose
 
Sadahisa Ogasawara
No Relationships to Disclose
 
Kazuo Watanabe
No Relationships to Disclose
 
Takatoshi Sahara
Employment - Eisai
 
Nozomi Hayata
Employment - Eisai
 
Shintaro Yamamuro
Employment - Eisai
Stock and Other Ownership Interests - Eisai; Eisai (I)
 
Takayuki Kimura
Employment - Eisai
 
Toshiyuki Tamai
Employment - Eisai
 
Masatoshi Kudo
Honoraria - AstraZeneca; Bayer; Chugai/Roche; Eisai; Lilly Japan; Takeda
Consulting or Advisory Role - AstraZeneca; Chugai/Roche; Eisai
Research Funding - Abbvie (Inst); Chugai/Roche (Inst); EA Pharma (Inst); Eisai (Inst); GE Healthcare (Inst); Gilead Sciences (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst)